Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Post-COVID-19
NCT06267300Phase 3Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
A Phase 3 trial of hyperbaric oxygen therapy in Post COVID-19 Syndrome (PCS), sponsored by Erasmus MC. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post COVID-19 Syndrome (PCS)
Beyond the preview
Go deeper on NCT06267300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06267300.